BLUE bluebird bio 添加自选 4.080 -2.960-42.05% 收盘价 02/21 16:00 (美东) 3.990 -0.090-2.21% 盘后20:01 (美东) 3966.66万总市值-0.11市盈率TTM 5.650最高价4.000最低价544.27万股成交量4.900今开7.040昨收2370.10万成交额56.35%换手率亏损市盈率(静)972.22万总股本38.40052周最高-6.80市净率3940.80万流通...
BLUE Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced -64.54% bluebird bio, Inc. price and volume Combination chart with 2 data series. Chart represents bluebird bio, Inc. price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The chart has 2 Y...
Bluebird Bio price target adjusted for stock split at Barclays Dec. 31, 2024 at 5:25 a.m. ETon TipRanks.com Bluebird Bio’s Strategic Restructuring and Valuation Uplift Justifies Buy Rating Dec. 30, 2024 at 8:35 p.m. ETon TipRanks.com ...
Get the latest bluebird bio Inc. (BLUE) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
富国银行:维持bluebird bio(BLUE.US)评级,由持股观望调整至持股观望评级, 目标价由40.00美元调整至5.00美元。 bluebird bio(BLUE.US)公司简介:Bluebird Bio Inc是一家生物技术公司,基于其专有的慢病毒载体( LVV )基因添加平台,致力于研究、开发和商业化针对严重遗传病的潜在治愈基因疗法。 该公司在单一部门运营,专...
Bluebird Bio Company Info Bluebird Bio is a development-stage biotechnology company focused on gene therapy, gene editing, and cancer immunotherapy. News & Analysis The Fool has written over 300 articles on Bluebird Bio. Featured Article Is Bluebird Bio Stock a Buy? It won't be easy for the...
Down 30% in a Week, What in the World Is Going On With Bluebird Bio Stock? Yahoo Finance • last year bluebird bio Details Plans for the Commercial Launch of LYFGENIA™ Gene Therapy for Patients Ages 12 and Older with Sickle Cell Disease and a History of Vaso-Occlusive Events Yah...
Bluebird bio Inc Competitors - Telecommunications Equipment Company Price USD Returns 1-YEAR RETURNS 5-year Elanco Animal Health Inc ELAN $11.52 27.86% 18.22% Arcus Biosciences Inc RCUS $12.55 20.62% 1.45% Nuvation Bio Inc - Ordinary Shares - Class A NUVB $2.38 35.23% - Lineage Cell Therapeut...
Latest bluebird bio Inc (BLE0:BER) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
bluebird bio, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Xxxxxxxxx LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s common stock, par value $0.01...